Stay updated with breaking news from Bone Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigators believe targeted immunomodulation with SEL-212 may have the potential to introduce a new uricase-based therapy for patients with gout refractory to conventional treatment.
Findings imply that Mod GRF (1-29) combined with GHRP-6 may increase growth hormone release and improve results above either peptide alone.
Get latest articles and stories on Health at LatestLY. Ageing results in an increase in a cellular signal necessary for the skeleton's development, which weakens bones, according to a new study in mice. The study, led by researchers from NYU Grossman School of Medicine, found that blocking the signaling pathway, called Notch, in aging skeletal stem cells caused a “massive increase” in bone mass and restored lost bone-healing ability during ageing. Health News | Inhibiting Aberrant Stem Cell Signals During Ageing Reduces Bone Loss: Study.
A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice.
The study finds that the cell signal that is crucial to skeleton development, weakens bones during aging. | Health